DRW8 Drägerwerk AG & Co. KGaA

XETRA · DE · Healthcare · Medical Devices · draeger.com

88.00EUR-1.79%Mkt Cap: 1.79B $P/E: 9.65Today

Drägerwerk AG & Co. KGaA operates as a medical and safety technology company worldwide. It develops, produces, and markets system solutions, devices, and services for the medical division, including emergency medicine, p…

Industry Peers

Medical Devices

Screen all

ABT

Abbott Laboratories Common Stock

$169.83BUSDP/E 31.6

MDT

Medtronic plc. Ordinary Shares

$110.49BUSDP/E 21.2

SYK

Stryker Corporation Common Stock

$105.65BUSDP/E 28.5

BSX

Boston Scientific Corporation Common Stock

$61.74BUSDP/E 17.2

Edwards Lifesciences Corporation Common Stock

$49.03BUSDP/E 50.7

SHL

Siemens Healthineers AG

$46.06BUSDP/E 19.2

DXCM

DexCom, Inc. - Common Stock

$32.21BUSDP/E 33.7

GEHC

GE HealthCare Technologies Inc. - Common Stock

$29.24BUSDP/E 14.8

PHG

Koninklijke Philips N.V. NY Registry Shares

$23.38BUSDP/E 18.5

PHIA

Koninklijke Philips N.V.

$22.58BUSDP/E 18.5

STE

STERIS plc (Ireland) Ordinary Shares

Zimmer Biomet Holdings, Inc. Common Stock

$16.84BUSDP/E 21.4

PEN

Penumbra, Inc. Common Stock

$12.51BUSDP/E 77.8

TXG

10x Genomics, Inc. - Common Stock

$12.18BUSD

SNN

Smith & Nephew SNATS, Inc. Common Stock

$11.06BUSDP/E 18.0

GMED

Globus Medical, Inc. Class A Common Stock

Bio-Rad Laboratories, Inc. Class A Common Stock

$9.88BUSDP/E 45.0

GKOS

Glaukos Corporation Common Stock

$9.66BUSD

Key Statistics

Company

Market Cap1.79B USD

Enterprise Value2.03B USD

Revenue (TTM)3.89B USD

Gross Profit1.71B USD

Net Income (TTM)151.63M USD

Revenue/Share190.56 EUR

Last Price88.00 EUR

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees16.0K

CountryDE

SectorHealthcare

IndustryMedical Devices

ISIN—

Valuation

P/E (Trailing)9.65

P/E (Forward)12.72

PEG1.94

EV/EBITDA6.01

EV/Revenue0.52

P/S0.47

P/B1.01

EPS (TTM)9.12

EPS (Forward)7.05

52W Range

50.6082% of range96.00

52W High96.00 EUR

52W Low50.60 EUR

Profitability

Gross Margin45.22%

Oper. Margin4.44%

EBITDA Margin8.72%

Profit Margin4.01%

ROE8.58%

ROA4.41%

Growth

Revenue Growth8.60%

Earnings Growth162.10%

Cash Flow & Leverage

Operating CF259.05M USD

CapEx (TTM)87.70M USD

FCF Margin3.21%

FCF Yield6.96%

Net Debt206.43M USD

Net Debt/EBITDA0.61

Balance Sheet

Debt/Equity0.25

Current Ratio2.05

Quick Ratio1.17

Book Value/Sh88.51 EUR

Cash/Share10.58 EUR

Dividends

Fwd Div Rate2.21 EUR

Trail. Div Rate2.27 EUR

Div. Yield2.47%

5Y Avg Yield0.53%

Payout Ratio24.23%

Ex-Div DateMay 11, 2026

Pay Date—

Analyst Consensus

Rating—

Target (Mean)89.00 EUR

Upside (mean)+1.1%

Target Range89.00 EUR – 89.00 EUR

# Analysts1

Ownership

Shares Out.10.16M

Float10.57M

Insiders71.62%

Institutions8.87%

Technical

SMA 5084.80 (+3.8%)

SMA 20073.80 (+19.2%)

Beta0.63

S&P 52W Chg14.58%

Avg Vol (30d)2.77K

Avg Vol (10d)4.29K

Technical Indicators

RSI (14)57.6

MACD2.2336

MACD Signal2.1870

MACD Hist.+0.0466

BB Upper94.89 EUR

BB Middle87.71 EUR

BB Lower80.53 EUR

BB Width16.38%

ATR (14)2.399 EUR

Vol Ratio (20d)0.30x